Ministry of National Planning and Economic Development

Medolife Rx Presents Its Venom-To-Drug Development Projects at an International Conference Held in the Dominican Republic

Retrieved on: 
Tuesday, January 11, 2022

Medolife is also committed to hire and train more female employees in 2022.

Key Points: 
  • Medolife is also committed to hire and train more female employees in 2022.
  • CEO of Medolife Dr. Arthur Mikaelian led discussions on the Companys projects with various representatives of the international committee during the conference.
  • Some members of the conference expressed interest in presenting our project to their respective countries, said Dr. Mikaelian.
  • Medolife Rx, Inc. is a global biotechnology company with operations in clinical research, manufacturing, and consumer products.